regulatory
confidence high
sentiment negative
materiality 0.60
Bridgeline Digital, Inc. (BLIN): Nasdaq/NYSE listing notice — Bridgeline Digital receives Nasdaq bid price deficiency notice; 180 days to cure
Bridgeline Digital, Inc.
- Nasdaq notified Bridgeline (BLIN) that its stock failed to maintain minimum $1.00 bid price for 30 consecutive business days ending May 2, 2023.
- Company has 180 calendar days, until October 30, 2023, to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not cured, Bridgeline may qualify for an additional 180-day grace period if it meets other Nasdaq Capital Market listing standards.
- The deficiency letter does not immediately affect listing; stock continues trading on Nasdaq under symbol BLIN.
- Bridgeline will monitor bid price and evaluate options to cure the deficiency.